Production (Stage)
Tiziana Life Sciences Ltd
TLSA
$1.58
$0.2115.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.00% | 68.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 42.72% | |||
| Operating Income | 0.00% | -42.72% | |||
| Income Before Tax | 0.00% | -9.85% | |||
| Income Tax Expenses | 0.00% | 53.19% | |||
| Earnings from Continuing Operations | 0.00% | -54.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -54.90% | |||
| EBIT | 0.00% | -42.72% | |||
| EBITDA | 0.00% | -42.84% | |||
| EPS Basic | 0.00% | -44.69% | |||
| Normalized Basic EPS | 0.00% | -25.26% | |||
| EPS Diluted | 0.00% | -44.69% | |||
| Normalized Diluted EPS | 0.00% | -25.26% | |||
| Average Basic Shares Outstanding | 0.00% | 6.93% | |||
| Average Diluted Shares Outstanding | 0.00% | 6.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||